Industry: Medical Devices & Consumables
Published Date: 2026-03-24
Pages: 93 Pages
Report ld: 6271622
Request Sample
Customized Report
MEMS Ophthalmic Drug Delivery System Market Size(US$)

CAGR 2026-2032
4.0%
Market Size,2032
USD 464
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global MEMS Ophthalmic Drug Delivery System market size was US$ 354 million in 2025 and is forecast to reach a readjusted size of US$ 464 million by 2032 with a CAGR of 4.0% during the forecast period 2026-2032.
MEMS (Micro-Electro-Mechanical Systems) ophthalmic drug delivery system is an ocular drug delivery system designed using micro-electro-mechanical systems technology. This kind of system usually has the characteristics of small size, strong function, low price and high reliability. Among them, the micropump serves as the "heart" of the microsystem and provides the main power for fluid transportation.
In 2025, the North America MEMS Ophthalmic Drug Delivery System market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of MEMS Ophthalmic Drug Delivery System include Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, inc., Gaplast GmbH, Gerresheimer, Nemera, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global MEMS Ophthalmic Drug Delivery System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of MEMS Ophthalmic Drug Delivery System sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of MEMS Ophthalmic Drug Delivery System manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, MEMS Ophthalmic Drug Delivery System product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the MEMS Ophthalmic Drug Delivery System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 MEMS Ophthalmic Drug Delivery System Product Scope
1.2 MEMS Ophthalmic Drug Delivery System by Type
1.2.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2021, 2025 & 2032)
1.2.2 Ophthalmic Mini Pump
1.2.3 Ophthalmic Injection Needle
1.2.4 Implantable Gel
1.2.5 Others
1.3 MEMS Ophthalmic Drug Delivery System by Application
1.3.1 Global MEMS Ophthalmic Drug Delivery System Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Global MEMS Ophthalmic Drug Delivery System Market Estimates and Forecasts (2021-2032)
1.4.1 Global MEMS Ophthalmic Drug Delivery System Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global MEMS Ophthalmic Drug Delivery System Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global MEMS Ophthalmic Drug Delivery System Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global MEMS Ophthalmic Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global MEMS Ophthalmic Drug Delivery System Historical Market Scenario by Region (2021-2026)
2.2.1 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2026)
2.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2026)
2.3 Global MEMS Ophthalmic Drug Delivery System Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global MEMS Ophthalmic Drug Delivery System Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global MEMS Ophthalmic Drug Delivery System Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America MEMS Ophthalmic Drug Delivery System Market Size and Prospects (2021-2032)
2.4.2 Europe MEMS Ophthalmic Drug Delivery System Market Size and Prospects (2021-2032)
2.4.3 China MEMS Ophthalmic Drug Delivery System Market Size and Prospects (2021-2032)
2.4.4 Japan MEMS Ophthalmic Drug Delivery System Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global MEMS Ophthalmic Drug Delivery System Historical Market Review by Type (2021-2026)
3.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2021-2026)
3.1.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2021-2026)
3.1.3 Global MEMS Ophthalmic Drug Delivery System Average Price by Type (2021-2026)
3.2 Global MEMS Ophthalmic Drug Delivery System Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global MEMS Ophthalmic Drug Delivery System Sales Forecast by Type (2027-2032)
3.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue Forecast by Type (2027-2032)
3.2.3 Global MEMS Ophthalmic Drug Delivery System Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of MEMS Ophthalmic Drug Delivery System
4 Global Market Size by Application
4.1 Global MEMS Ophthalmic Drug Delivery System Historical Market Review by Application (2021-2026)
4.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2021-2026)
4.1.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2021-2026)
4.1.3 Global MEMS Ophthalmic Drug Delivery System Average Price by Application (2021-2026)
4.2 Global MEMS Ophthalmic Drug Delivery System Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global MEMS Ophthalmic Drug Delivery System Sales Forecast by Application (2027-2032)
4.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue Forecast by Application (2027-2032)
4.2.3 Global MEMS Ophthalmic Drug Delivery System Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in MEMS Ophthalmic Drug Delivery System Applications
5 Competition Landscape by Players
5.1 Global MEMS Ophthalmic Drug Delivery System Sales by Player (2021-2026)
5.2 Global Top MEMS Ophthalmic Drug Delivery System Players by Revenue (2021-2026)
5.3 Global MEMS Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on MEMS Ophthalmic Drug Delivery System revenue as of 2025
5.4 Global MEMS Ophthalmic Drug Delivery System Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Product Type & Application
5.7 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America MEMS Ophthalmic Drug Delivery System Sales by Company
6.1.1.1 North America MEMS Ophthalmic Drug Delivery System Sales by Company (2021-2026)
6.1.1.2 North America MEMS Ophthalmic Drug Delivery System Revenue by Company (2021-2026)
6.1.2 North America MEMS Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
6.1.3 North America MEMS Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
6.1.4 North America MEMS Ophthalmic Drug Delivery System Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe MEMS Ophthalmic Drug Delivery System Sales by Company
6.2.1.1 Europe MEMS Ophthalmic Drug Delivery System Sales by Company (2021-2026)
6.2.1.2 Europe MEMS Ophthalmic Drug Delivery System Revenue by Company (2021-2026)
6.2.2 Europe MEMS Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
6.2.3 Europe MEMS Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
6.2.4 Europe MEMS Ophthalmic Drug Delivery System Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China MEMS Ophthalmic Drug Delivery System Sales by Company
6.3.1.1 China MEMS Ophthalmic Drug Delivery System Sales by Company (2021-2026)
6.3.1.2 China MEMS Ophthalmic Drug Delivery System Revenue by Company (2021-2026)
6.3.2 China MEMS Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
6.3.3 China MEMS Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
6.3.4 China MEMS Ophthalmic Drug Delivery System Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan MEMS Ophthalmic Drug Delivery System Sales by Company
6.4.1.1 Japan MEMS Ophthalmic Drug Delivery System Sales by Company (2021-2026)
6.4.1.2 Japan MEMS Ophthalmic Drug Delivery System Revenue by Company (2021-2026)
6.4.2 Japan MEMS Ophthalmic Drug Delivery System Sales Breakdown by Type (2021-2026)
6.4.3 Japan MEMS Ophthalmic Drug Delivery System Sales Breakdown by Application (2021-2026)
6.4.4 Japan MEMS Ophthalmic Drug Delivery System Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Mati Therapeutics
7.1.1 Mati Therapeutics Company Information
7.1.2 Mati Therapeutics Business Overview
7.1.3 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Products Offered
7.1.5 Mati Therapeutics Recent Development
7.2 Amorphex Therapeutics
7.2.1 Amorphex Therapeutics Company Information
7.2.2 Amorphex Therapeutics Business Overview
7.2.3 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Products Offered
7.2.5 Amorphex Therapeutics Recent Development
7.3 Aero Pump GmbH
7.3.1 Aero Pump GmbH Company Information
7.3.2 Aero Pump GmbH Business Overview
7.3.3 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Products Offered
7.3.5 Aero Pump GmbH Recent Development
7.4 AptarGroup
7.4.1 AptarGroup Company Information
7.4.2 AptarGroup Business Overview
7.4.3 AptarGroup MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.4.4 AptarGroup MEMS Ophthalmic Drug Delivery System Products Offered
7.4.5 AptarGroup Recent Development
7.5 Bausch Health
7.5.1 Bausch Health Company Information
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Bausch Health MEMS Ophthalmic Drug Delivery System Products Offered
7.5.5 Bausch Health Recent Development
7.6 Becton Dickinson & Company
7.6.1 Becton Dickinson & Company Company Information
7.6.2 Becton Dickinson & Company Business Overview
7.6.3 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Products Offered
7.6.5 Becton Dickinson & Company Recent Development
7.7 EyePoint Pharmaceuticals, inc.
7.7.1 EyePoint Pharmaceuticals, inc. Company Information
7.7.2 EyePoint Pharmaceuticals, inc. Business Overview
7.7.3 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.7.4 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Products Offered
7.7.5 EyePoint Pharmaceuticals, inc. Recent Development
7.8 Gaplast GmbH
7.8.1 Gaplast GmbH Company Information
7.8.2 Gaplast GmbH Business Overview
7.8.3 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Products Offered
7.8.5 Gaplast GmbH Recent Development
7.9 Gerresheimer
7.9.1 Gerresheimer Company Information
7.9.2 Gerresheimer Business Overview
7.9.3 Gerresheimer MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Gerresheimer MEMS Ophthalmic Drug Delivery System Products Offered
7.9.5 Gerresheimer Recent Development
7.10 Nemera
7.10.1 Nemera Company Information
7.10.2 Nemera Business Overview
7.10.3 Nemera MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Nemera MEMS Ophthalmic Drug Delivery System Products Offered
7.10.5 Nemera Recent Development
7.11 Nipro Corporation
7.11.1 Nipro Corporation Company Information
7.11.2 Nipro Corporation Business Overview
7.11.3 Nipro Corporation MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Nipro Corporation MEMS Ophthalmic Drug Delivery System Products Offered
7.11.5 Nipro Corporation Recent Development
7.12 Ocular Therapeutix
7.12.1 Ocular Therapeutix Company Information
7.12.2 Ocular Therapeutix Business Overview
7.12.3 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Products Offered
7.12.5 Ocular Therapeutix Recent Development
8 MEMS Ophthalmic Drug Delivery System Manufacturing Cost Analysis
8.1 MEMS Ophthalmic Drug Delivery System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of MEMS Ophthalmic Drug Delivery System
8.4 MEMS Ophthalmic Drug Delivery System Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 MEMS Ophthalmic Drug Delivery System Distributors List
9.3 MEMS Ophthalmic Drug Delivery System Customers
10 MEMS Ophthalmic Drug Delivery System Market Dynamics
10.1 MEMS Ophthalmic Drug Delivery System Industry Trends
10.2 MEMS Ophthalmic Drug Delivery System Market Drivers
10.3 MEMS Ophthalmic Drug Delivery System Market Challenges
10.4 MEMS Ophthalmic Drug Delivery System Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 354 million in 2025 to US$ 464 million by 2032, at a CAGR of 4.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 151
USD 4900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 354 million in 2025 and is projected to reach US$ 464 million, growing at a CAGR of 4.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market was valued at US$ 354 million in 2025 and is anticipated to reach US$ 464 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 2900.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market size was US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 97
USD 4250.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 330 million in 2024 to US$ 433 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 156
USD 4900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 122
USD 3950.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published Date: 2025-03-10
Pages: 91
USD 2900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 129
USD 3950.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2023 and is projected to reach a revised size of US$ 433 million by 2030, growing at a CAGR of 4.0% during the forecast period.
Published Date: 2025-01-04
Pages: 93
USD 2900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 433 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 115
USD 3950.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 354 million in 2025 to US$ 464 million by 2032, at a CAGR of 4.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 151
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 354 million in 2025 and is projected to reach US$ 464 million, growing at a CAGR of 4.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global MEMS Ophthalmic Drug Delivery System market was valued at US$ 354 million in 2025 and is anticipated to reach US$ 464 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
The global MEMS Ophthalmic Drug Delivery System market size was US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 97
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 330 million in 2024 to US$ 433 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 156
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 122
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published: 2025-03-10
Pages: 91
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 129
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2023 and is projected to reach a revised size of US$ 433 million by 2030, growing at a CAGR of 4.0% during the forecast period.
Published: 2025-01-04
Pages: 93
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 433 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now